LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Partnerships Cedilla Therapeutics has recently partnered with Bayer to develop and commercialize CyclinE1/CDK2 complex inhibitors in precision oncology, presenting an opportunity for joint sales initiatives and expanding market reach.

Funding Growth With successful fundraising rounds totaling $107.6M in recent years, including Series B financing, Cedilla Therapeutics exhibits financial stability which can facilitate larger purchases and long-term partnerships for sales development.

Lead Drug Programs The launch of two lead drug programs targeting solid tumors and CDK4/6-resistant tumors positions Cedilla Therapeutics as an emerging player in precision oncology, creating avenues for targeted marketing and sales strategies.

Key Personnel Acquisition Appointment of Véronique Riethuisen as Chief Business Officer and Head of Finance showcases Cedilla Therapeutics' focus on strategic leadership, opening doors for key account management and high-level sales engagements.

Research Collaboration Partnership with HitGen Ltd for research collaboration signifies Cedilla Therapeutics' commitment to innovation and industry collaborations, presenting opportunities for joint product development and co-marketing strategies.

Similar companies to Cedilla Therapeutics

Cedilla Therapeutics Tech Stack

Cedilla Therapeutics uses 8 technology products and services including Google Analytics, PostgreSQL, MySQL, and more. Explore Cedilla Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • PostgreSQL
    Database
  • MySQL
    Database
  • Typekit
    Font Scripts
  • Google Font API
    Font Scripts
  • Open Graph
    Miscellaneous
  • Cisco Meraki
    Network Hardware
  • WP Engine
    Platform As A Service

Media & News

Cedilla Therapeutics's Email Address Formats

Cedilla Therapeutics uses at least 1 format(s):
Cedilla Therapeutics Email FormatsExamplePercentage
FLast@cedillatx.comJDoe@cedillatx.com
50%
FLast@cedillatx.comJDoe@cedillatx.com
50%

Frequently Asked Questions

Where is Cedilla Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Cedilla Therapeutics's main headquarters is located at 245 First Street 3rd Floor Cambridge, Massachusetts 02142 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Cedilla Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Cedilla Therapeutics's official website is cedillatx.com and has social profiles on LinkedIn.

How much revenue does Cedilla Therapeutics generate?

Minus sign iconPlus sign icon
As of April 2022, Cedilla Therapeutics's annual revenue reached $3.8M.

What is Cedilla Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Cedilla Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cedilla Therapeutics have currently?

Minus sign iconPlus sign icon
As of April 2022, Cedilla Therapeutics has approximately 46 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Co-Founder: A. D.Marketing Manager: A. N.Scientist: S. G.. Explore Cedilla Therapeutics's employee directory with LeadIQ.

What industry does Cedilla Therapeutics belong to?

Minus sign iconPlus sign icon
Cedilla Therapeutics operates in the Biotechnology Research industry.

What technology does Cedilla Therapeutics use?

Minus sign iconPlus sign icon
Cedilla Therapeutics's tech stack includes Google AnalyticsPostgreSQLMySQLTypekitGoogle Font APIOpen GraphCisco MerakiWP Engine.

What is Cedilla Therapeutics's email format?

Minus sign iconPlus sign icon
Cedilla Therapeutics's email format typically follows the pattern of . Find more Cedilla Therapeutics email formats with LeadIQ.

How much funding has Cedilla Therapeutics raised to date?

Minus sign iconPlus sign icon
As of April 2022, Cedilla Therapeutics has raised $25M in funding. The last funding round occurred on Oct 25, 2021 for $25M.

When was Cedilla Therapeutics founded?

Minus sign iconPlus sign icon
Cedilla Therapeutics was founded in 2018.
Cedilla Therapeutics

Cedilla Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

For 60 years, sequence and structure has been the primary lens to understand protein function. It’s now time to look beyond and leverage the orchestration of protein function within cells. 

Cedilla Therapeutics is bringing a new dimension to precision oncology. We have discovered new ways to selectively inhibit oncogenic drivers with small molecules that conditionally modulate proteins in their functional state. Our conditional inhibitors are unlocking critical and elusive cancer targets including TEAD and CDK2. 

We are a driven and patient-focused team. 

Section iconCompany Overview

Headquarters
245 First Street 3rd Floor Cambridge, Massachusetts 02142 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $25M

    Cedilla Therapeutics has raised a total of $25M of funding over 3 rounds. Their latest funding round was raised on Oct 25, 2021 in the amount of $25M.

  • $10M

    Cedilla Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $25M

    Cedilla Therapeutics has raised a total of $25M of funding over 3 rounds. Their latest funding round was raised on Oct 25, 2021 in the amount of $25M.

  • $10M

    Cedilla Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.